Form 4 Tracker
John A. Lewicki

Chief Scientific Officer · 1 filing · Latest: Feb 1, 2026

Mereo BioPharma Group plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MREO
Lewicki John A.Sep 12, 2024
Proposed Sale
$4.6616,149$75.3K